MICROALBUMINURIA is associated with left ventricular hypertrophy (LVH) in the general population, new data suggest.

TREATMENT WITH a gonadotropin-releasing hormone (GnRH) agonist is associated with increased risks of diabetes, coronary heart disease (CHD), MI, and sudden cardiac death in men with prostate cancer, according to an observational study at Harvard Medical School in Boston.

EXPRESSION OF cyclooxygenase-2 (COX-2) in prostate cancer tissue is an independent predictor of biochemical recurrence following radical prostatectomy.

AFRICAN-AMERICAN (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.

NAFTOPIDIL is effective first-line monotherapy for patients with storage symptoms associated with benign prostatic hyperplasia (BPH), according to researchers in Japan.

TREATMENT WITH rapamycin may be associated with myoglobinuria and severe acute renal failure (ARF) following renal transplantation, according to a new study.

PATIENTS WITH intermediate-risk prostate cancer may be effectively treated with brachytherapy without supplemental pelvic radiotherapy, according to new findings.

CKD IS independently associated with an increased risk of ischemic stroke and transient ischemic attack (TIA) in patients with pre-existing atherothrombotic disease, new findings suggest.

GLUCOSE CONTROL influences glomerular filtration rate (GFR) and its estimations in patients with type 1 or 2 diabetes, a French study found.